Background <p>The expired S3-DEGAM (<i>Deutsche Gesellschaft für Allgemeinmedizin und Familienmedizin</i>) guideline was revised on an interdisciplinary basis for the period from 2021 to 2025 and published in 2025 as the S2K-DEGAM guideline “Dizziness in General Practice”. It is also aimed at physicians specializing in otolaryngology (ENT), neurology, internal medicine, radiology, psychotherapy, and physiotherapy. With an annual prevalence of 2%–5%, the symptom of vertigo is a&#xa0;constant reason for consultation in general practice, and even more frequently in neurology and ENT.</p> Methods <p>For their draft texts, the author groups took into account the results of keyword searches in MEDLINE (via PubMed) and Embase, supplemented by manual findings. Draft texts were reviewed, supplemented, discussed and, where necessary, amended by all authors jointly. The classification as an S2k guideline was agreed upon in consensus with the participating professional societies and the SLQ (<i>Sektion Leitlinien und Qualitätsförderung</i>) of the DEGAM. Recommendations and final wording were agreed upon at two externally moderated consensus conferences with the participation of a&#xa0;patient representative.</p> Key recommendations <p>Many causes of vertigo including dizziness, are harmless, albeit unsettling. Symptomatic antivertigo drugs should be used for symptomatic treatment if necessary, but should be limited to 3&#xa0;days if possible. If warning symptoms occur, rapid treatment or referral of the patients is necessary. Warning symptoms include sensory disturbances or paralysis, double vision, coordination disorders, impaired consciousness, syncope and others. Vertigo may be the only symptom of an acute cerebrovascular event. In cases of assumed acute vestibular syndrome (AVS) with persistent severe acute vertigo with nystagmus, the HINTSplus test should be performed by trained physicians to detect signs pointing towards a&#xa0;possible central nervous system event.</p>

错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

„Schwindel in der Hausarztpraxis“ – eine neue DEGAM-Leitlinie

  • Detmar Jobst,
  • Ralf Jendyk

摘要

Background

The expired S3-DEGAM (Deutsche Gesellschaft für Allgemeinmedizin und Familienmedizin) guideline was revised on an interdisciplinary basis for the period from 2021 to 2025 and published in 2025 as the S2K-DEGAM guideline “Dizziness in General Practice”. It is also aimed at physicians specializing in otolaryngology (ENT), neurology, internal medicine, radiology, psychotherapy, and physiotherapy. With an annual prevalence of 2%–5%, the symptom of vertigo is a constant reason for consultation in general practice, and even more frequently in neurology and ENT.

Methods

For their draft texts, the author groups took into account the results of keyword searches in MEDLINE (via PubMed) and Embase, supplemented by manual findings. Draft texts were reviewed, supplemented, discussed and, where necessary, amended by all authors jointly. The classification as an S2k guideline was agreed upon in consensus with the participating professional societies and the SLQ (Sektion Leitlinien und Qualitätsförderung) of the DEGAM. Recommendations and final wording were agreed upon at two externally moderated consensus conferences with the participation of a patient representative.

Key recommendations

Many causes of vertigo including dizziness, are harmless, albeit unsettling. Symptomatic antivertigo drugs should be used for symptomatic treatment if necessary, but should be limited to 3 days if possible. If warning symptoms occur, rapid treatment or referral of the patients is necessary. Warning symptoms include sensory disturbances or paralysis, double vision, coordination disorders, impaired consciousness, syncope and others. Vertigo may be the only symptom of an acute cerebrovascular event. In cases of assumed acute vestibular syndrome (AVS) with persistent severe acute vertigo with nystagmus, the HINTSplus test should be performed by trained physicians to detect signs pointing towards a possible central nervous system event.